We are live on
!
Find out more
Vanguard Investments Australia Portfolio holdings
AUM
$40.2B
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$34.6B
AUM Growth
–
Cap. Flow
+$36B
Cap. Flow
% of AUM
103.96%
Top 10 Holdings %
Top 10 Hldgs %
31.34%
Holding
2,379
New
2,379
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.22B |
| 2 |
Apple
AAPL
|
+$1.91B |
| 3 |
Microsoft
MSFT
|
+$1.48B |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.25B |
| 5 |
Amazon
AMZN
|
+$1.06B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.25% |
| 2 | Financials | 11.63% |
| 3 | Consumer Discretionary | 8.93% |
| 4 | Communication Services | 8.9% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Matsons
MATX
$6.5B
| $324K | ﹤0.01% |
+1,975
| New | +$307K |
|
1802
Tandem Diabetes Care
TNDM
$1.58B
| $324K | ﹤0.01% |
+16,889
| New | +$367K |
|
|
DEC
1803
Diversified Energy Company
DEC
$1.01B
| $323K | ﹤0.01% |
+18,514
| New | +$261K |
|
1804
Reynolds Consumer Products
REYN
$5.53B
| $323K | ﹤0.01% |
+15,232
| New | +$349K |
|
|
PVLA
1805
Palvella Therapeutics
PVLA
$2.25B
| $322K | ﹤0.01% |
+2,586
| New | +$270K |
|
1806
NewAmsterdam Pharma
NAMS
$3.23B
| $321K | ﹤0.01% |
+10,027
| New | +$327K |
|
1807
DoubleVerify
DV
$2.04B
| $321K | ﹤0.01% |
+33,777
| New | +$345K |
|
1808
Full Truck Alliance
YMM
$9.14B
| $320K | ﹤0.01% |
+38,558
| New | +$367K |
|
1809
Astec Industries
ASTE
$997M
| $320K | ﹤0.01% |
+5,941
| New | +$319K |
|
1810
Ocular Therapeutix
OCUL
$2.2B
| $319K | ﹤0.01% |
+37,615
| New | +$359K |
|
1811
QCR Holdings
QCRH
$1.74B
| $318K | ﹤0.01% |
+3,716
| New | +$324K |
|
1812
GeneDx Holdings
WGS
$2.33B
| $317K | ﹤0.01% |
+4,943
| New | +$451K |
|
1813
Napco Security Technologies
NSSC
$1.37B
| $317K | ﹤0.01% |
+8,036
| New | +$337K |
|
1814
Viridian Therapeutics
VRDN
$2.5B
| $316K | ﹤0.01% |
+16,170
| New | +$480K |
|
1815
Federal Agricultural Mortgage
AGM
$2.53B
| $316K | ﹤0.01% |
+2,131
| New | +$349K |
|
1816
Alphatec Holdings
ATEC
$1.51B
| $316K | ﹤0.01% |
+29,041
| New | +$423K |
|
1817
NovoCure
NVCR
$1.97B
| $315K | ﹤0.01% |
+28,900
| New | +$361K |
|
1818
Southside Bancshares
SBSI
$986M
| $315K | ﹤0.01% |
+10,117
| New | +$321K |
|
1819
Central Pacific Financial
CPF
$996M
| $314K | ﹤0.01% |
+9,817
| New | +$316K |
|
1820
Simply Good Foods
SMPL
$1B
| $314K | ﹤0.01% |
+21,853
| New | +$377K |
|
1821
CBIZ
CBZ
$2.96B
| $313K | ﹤0.01% |
+11,653
| New | +$411K |
|
1822
CVR Energy
CVI
$3.54B
| $313K | ﹤0.01% |
+9,291
| New | +$239K |
|
1823
Kodiak Sciences
KOD
$2.6B
| $313K | ﹤0.01% |
+8,200
| New | +$212K |
|
1824
Biohaven
BHVN
$2.21B
| $311K | ﹤0.01% |
+36,803
| New | +$403K |
|
1825
AdaptHealth
AHCO
$775M
| $311K | ﹤0.01% |
+26,098
| New | +$267K |
|
Similar funds
SAM
CS
PPF
Vanguard Investments Australia's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Investments Australia, which disclosed 2,379 positions worth $34.6B. Its ten largest holdings account for 31% of the portfolio.
Its largest position is NVIDIA: 12,096,470 shares worth $2.11B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, followed by Financials and Consumer Discretionary.
- Vanguard Investments Australia's largest Q1 2026 buy was NVIDIA: 12,096,470 shares worth $2.11B.
- Vanguard Investments Australia's ten largest holdings make up 31% of its $34.6B portfolio in Q1 2026.
- Vanguard Investments Australia disclosed 2,379 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Investments Australia's 13F filing for Q1 2026, filed 8 May 2026.